Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
45,3 USD | +1,98% | -1,93% | -24,71% |
Attività
Numero di dipendenti: 1 800
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Cell Therapies
100,0
%
| 117 | 100,0 % | 285 | 100,0 % | +143,70% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
94,7
%
| 117 | 99,7 % | 270 | 94,7 % | +131,47% |
Europe
5,3
%
| 0 | 0,1 % | 15 | 5,3 % | +19.993,33% |
China
0,1
%
| 0 | 0,3 % | 0 | 0,1 % | -45,43% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 01/07/19 |
Lori Macomber
DFI | Director of Finance/CFO | 53 | 01/09/19 |
Tracy Luo
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/18 |
Liz Gosen
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/19 |
Guowei Fang
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Mythili Koneru
CTO | Chief Tech/Sci/R&D Officer | 46 | 11/04/23 |
- | - | ||
Jessie Yeung
IRC | Investor Relations Contact | - | 01/01/19 |
Elaine Qian
HRO | Human Resources Officer | - | 01/11/19 |
Yuhong Qiu
LAW | General Counsel | - | 01/05/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 01/07/19 |
Corazon Sanders
BRD | Director/Board Member | 67 | 01/05/20 |
Li Zhu
BRD | Director/Board Member | 74 | 23/11/20 |
Patrick J. Casey
BRD | Director/Board Member | 68 | 03/12/20 |
Fang Liang Zhang
CEO | Chief Executive Officer | 59 | 27/05/15 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 02/08/22 |
Ye Wang
BRD | Director/Board Member | 55 | 01/05/15 |
Wai Man Yau
BRD | Director/Board Member | 48 | 01/05/20 |
Xiao Hui Ji
BRD | Director/Board Member | 62 | 01/05/20 |
Li Mao
BRD | Director/Board Member | 67 | 02/08/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 363 822 069 | 360 183 848 ( 99,00 %) | 0 | 99,00 % |
Coordinate società
Settore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-24,71% | 8,24 Mrd | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione LEGN
- Società Legend Biotech Corporation